RegisterLogin

Compound 19A8.8

CAT: 0804-HY-P11227Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P11227Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Compound 19A8.8 is a cyclic peptide derived from a CD36 protein fragment. Compound 19A8.8 inhibits the TGF-β/Smad3 signaling pathway by suppressing the interaction between TSP1 and CD36. Compound 19A8.8 has no obvious cytotoxicity. Compound 19A8.8 can be used for research on colon injury and fibrosis[1].
UNSPSC
12352209
Target
TGF-beta/Smad; TGF-β Receptor
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Field of Research
Neurological Disease
Smiles
O=C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCC(N)=O)C(N[C@H]1CC(O)=O)=O)=O)=O)=O)=O)[C@H](CCCCN)NC1=O
Molecular Formula
C35H60N12O13
Molecular Weight
856.92
References & Citations
[1]Zhang W, et al. Design and discovery of novel cyclic peptides as TSP1-CD36 interaction inhibitors for intestinal fibrosis treatment. Bioorg Chem. 2025 Aug;163:108667.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-U00358Compound 2
HY-14176-01Compound E
HY-19341-01Compound 401
HY-131649-01Compound C108
HY-101730-01Antibacterial compound 2
HY-14176GCompound E (GMP)
HY-111405Antimicrobial Compound 1
HY-U00409Antiasthmatic Compound 1
HY-N10858Chisocheton compound F
HY-101819Antibacterial compound 1

Alternative Products

CatalogName
M45003APHA Compound 8
TPL0027-01Compound 199330-64-8
TPL0039-01Compound 17899-48-8
TPL0071-01Compound 1060815-90-8
TPL0080-01Compound 156496-39-8
TPL0093-01Compound 103646-82-8
TPL0134-01Compound 17965-71-8
TPL0227-01Compound 1251015-03-8
TPL0301-01Compound 78470-95-8
RG-T052025-01Tetradecane Related Compound 8

Popular Products